BackLumos Pharma Overview

Lumos Pharma Operating Income

Operating Income for LUMO.

Quarterly Operating Income

$-7640000.00
↓ 14.46% YoY

As of Sep 30, 2024

Annual Operating Income (TTM)

$-36329000.00
↑ 2.49% YoY

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin